This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.
Read the original research
Identification of Wandering Masses and Tumor Heterogeneity on 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT.
Journal of nuclear medicine technology, 52(3), 272-273
Citation
Baberwal, Parth; Parghane, Rahul; Basu, Sandip. (2024). Identification of Wandering Masses and Tumor Heterogeneity on 68Ga-DOTATATE and 18F-FDG PET/CT in Metastatic Grade II Neuroendocrine Tumor with Increased Somatostatin Receptor Expression After Combined Chemotherapy and PRRT.. Journal of nuclear medicine technology, 52(3), 272-273. https://doi.org/10.2967/jnmt.123.267286